The
report titled, "Worldwide Medical Polymer Markets 2013-2020"
identifies the current and future opportunities in the medical
polymers space and provides guidance on the technical and regulatory
framework in which these opportunities are arising.
Glen
Allen, Virginia (September 19, 2013) -- According to a new report
from industry analyst firm NanoMarkets,
the global medical polymer market will grow from $2.3 billion (USD)
in 2013 to over $3.5 billion in 2018. The report titled, "Worldwide
Medical Polymer Markets 2013-2020" identifies the current
and future opportunities in the medical polymers space and provides
guidance on the technical and regulatory framework in which these
opportunities are arising.
The
report also includes granular eight-year forecasts and an analysis of
the complete supply chain for medical polymers. Firms addressed
within the report include, Bayer MaterialScience, Celanese, Dow
Corning, Dow Chemical, DSM, DuPont, Eastman Chemical, Evonik, Solvay
and others.
Details
about the report are available at:
http://nanomarkets.net/market_reports/report/worldwide_medical_polymer_markets_2013_2020.
From
the Report:
Implants
currently consume about half the medical polymers produced and are
expected to account for around $1.6 billion in polymer sales by 2018.
Polymers have been penetrating the implant market because they are
lower cost and lighter weight than metal alternatives, such as
titanium. The report also indicates that increased use of medical
imaging is creating further demand for polymers.
According
to the new NanoMarkets report, sales of polymers for diagnostic
systems will reach $1.04 billion in 2018. In vitro diagnostics
account for 50,000 to 60,000 metric tons of specialized and commodity
plastics every year. Most diagnostic procedures today are rapid,
multi-assays, and plastics have become indispensable. The growth
prospects in this sector are thus particularly strong.
The
report claims that PMMA, PS/styrenics, and PP are the leading medical
polymers based on revenue accounting for around 26 percent of the
market in 2013. There are also some high-value niches appearing in
the market. Commercial elastomers that provide a "soft touch"
are being used to coat accessories, such as catheters, gloves, and
syringes, in order to impart a soft touch feel. Their use is expected
to grow in intravenous drug delivery systems, cardio systems, and
blood collection devices.
The
last decade has seen the rise of biodegradable polymers. The current
trend suggests that in the near future, entire prostheses will be
developed from these materials. While they will not be used to
manufacture diagnostic products, biodegradable polymers will be
incorporated into implants and some clinical labware. There is some
additional interest in discovering new biodegradable polymers for
medical applications, but investment in this area is limited due to
the need to complete extensive long-term studies in order to validate
new materials.
About
the Report:
This
new report provides the necessary strategic insight into how the
polymer industry can best generate new business revenues in medical
applications and where the medical device industry can expect polymer
materials to make their greatest impact. This report which polymers
are likely to do best in the medical environment. This study also
contains detailed eight-year forecasts in volume (Kg) and value
terms.
Readers
of this report will gain the following:
• An
analytical review of polymers used for medical applications,
including developing implants, diagnostic systems, and hospital
labware.
• Knowledge
on current technical and market trends, including general market
drivers for improvement in the healthcare sector, polymer production,
and evaluation for clinical approval.
• An
understanding of key medical products and their future implications.
• A
pin-pointed analysis of the changing dynamics of polymer producers.
• Eight–year
forecasts based on expected market growth.
• A
brief technological road map for understanding industry growth.
• Profiles
of major companies operating as manufacturers of medical polymers.
• Insight
into important geographical locations pertaining to polymer and
healthcare sectors.
• Information
on the size of the medical polymer market in developed nations and
the fast-growing economies in Asia, such as China and India.
• Details
of the regulatory requirements of these countries for producing
high-quality, medically approved polymers and their use in various
applications.
• Help
in making business decisions for venturing into the medical polymer
market.
• Descriptive
and distinctive graphics, along with concise, tabular analyses of
various domains.
About
NanoMarkets:
NanoMarkets
tracks and analyzes emerging markets in medical, energy, electronics
and other area created by developments in advanced materials. The
firm is a recognized leader in industry analysis and forecasts of in
the transparent conductor industry.
Visit
http://www.nanomarkets.net
for a full listing of NanoMarkets' reports and other services.
Media
Contact:
Robert
Nolan
NanoMarkets,
LC
PO
BOX 3840
Glen
Allen, VA 23058
(804)
938-0030
